PRDX2 and cancer: In contrast, PRDX2 overexpression is related to the development of several malignant tumors, consisting of cancers of the colon (Lu et al., 2014), cervix (Lomnytska et al., 2011), lung (Stresing et al., 2013), prostate (Ummanni et al., 2015), liver (Zhou et al., 2016), and esophagus (Feng et al., 2020).